Sentence examples for progression at high from inspiring English sources

Our results are consistent with a model of Alzheimer's disease in which Aβ deposition initiates the pathological cascade but is not the direct cause of cognitive impairment as evidenced by the fact that Aβ load severity is decoupled from risk of progression at high levels.

Further research needs to be done to understand its effects at different time points of cancer progression at higher doses.

A programme of assessment containing instruments structured to facilitate this process, could support learning and monitor progression at higher levels of professional development [ 7, 8].

Accordingly, in our data Aβ load severity is decoupled from time-to-progression at high levels.

The spatial evolution of soot, however, shifts from a relatively rapid filling of the downstream head of the jet at low dilution, to inception at the midstream periphery of the jet followed by a gradual progression downstream at high dilution.

Moreover, both AgNPs affected HepG2 cell cycle progression at the higher concentration (11 μg/mL) by increasing the percentage of cells in S (synthesis phase) and G2 (Gap 2 phase) phases.

The pattern of diminishing CD4-related progression risks at higher baseline CD4 (Figure 2c+d) was also observed in a recent multi-center analysis of patients starting immediate versus deferred ART [36]: Here, the prognostic value of CD4 − as measured by AIDS/death risks associated with deferring ART − was high at low CD4 thresholds, but marginal at thresholds in the range of 500 cells/µL.

Treatment with tumour necrosis factor inhibitors (TNF-i) plus methotrexate (MTX), but not MTX monotherapy alone, inhibits joint damage progression even at higher levels of disease activity.

Common approaches hypothesize that mutations conferring a selective advantage on tumor initiation and progression will occur at high frequency across a wide range of tumor samples.

In this work we identified CpG-island methylation profiles of cancer biomarker regulatory regions, with a deep impact on prognostic determination in breast cancer, and the ability to distinguish cases with limited or nil risk for progression from those at high risk.

The 5-year progression rate in those at high risk is 45% (Sylvester et al, 2006).